Key result
Fractional flow reserve (FFR) guided percutaneous coronary intervention resulted in no significant difference in major adverse cardiac events at 1 year compared to angiography guided PCI (OR 0.78, p=0.09).
Why the study?
The clinical outcomes of coronary revascularization guided by conventional angiography versus physiologically guided PCI using FFR or iFR at 1 year were unclear.
Does FFR or iFR guided PCI improve clinical outcomes compared to angiography guided PCI in patients with coronary artery disease?
Meta-Analysis (n=15,880)
Yes
Does FFR or iFR guided PCI improve clinical outcomes compared to angiography guided PCI in patients with coronary artery disease?
Odds Ratio: 0.78 (95% CI 0.59–1.04)
p-value: p=0.09
In this meta-analysis, FFR- and iFR-guided PCI did not significantly reduce 1-year major adverse cardiac events compared to angiography-guided PCI, and iFR was non-inferior to FFR.
The present study aimed to compare the clinical outcome of patients with coronary artery disease (CAD) who underwent a revascularization using conventional coronary angiography or a physiologically guided revascularization with Fractional Flow Reserve (FFR). Furthermore, outcomes in FFR guided percutaneous coronary intervention (PCI) and instantaneous wave‑free ratio (iFR) guided PCI were compared. The analysis was performed for reported outcomes at a 1‑year follow‑up. After searching PubMed, EMBASE, and Web of Science for suitable publications, a total of 15,880 subjects were included. Comparing angiography guided and FFR guided PCI showed no significant difference in major adverse cardiac events [odds ratio (OR), 0.78; 95% confidence interval (CI), 0.59‑1.04; P=0.09; I²=73%], death from any cause (OR, 0.74; 95% CI, 0.46‑1.18; P=0.20; I²=74%), myocardial infarction (OR, 0.93; 95% CI, 0.81‑1.07; P=0.31; I²=0%) or unplanned revascularization (OR, 0.71; 95% CI, 0.41‑1.23; P=0.22; I²=79%). In addition, no significant difference could be found between iFR and FFR guided PCI for major adverse cardiac events (OR, 0.97; 95% CI; 0.76‑1.23; P=0.81; I²=0%), death from any cause (OR, 0.66; 95% CI, 0.40‑1.11; P=0.12; I²=0%), myocardial infarction (OR, 0.83; 95% CI, 0.56‑1.24; P=0.37) or unplanned revascularization (OR, 1.16; 95% CI, 0.85‑1.58; P=0.34; I²=16%). Overall, there was a tendency towards better outcomes of FFR in all four clinical endpoints compared with angiography guiding of PCI, and furthermore iFR showed no significant inferiority when compared to FFR in said clinical endpoints. When conducting a network meta‑analysis, the results confirmed a non‑inferiority of iFR compared to angiography guided revascularization.
No takes yet. Share an insight, caveat, or question.
Baumann et al. (2019) conducted a meta-analysis in Coronary artery disease (CAD) (n=15,880). Fractional Flow Reserve (FFR) guided PCI vs. Angiography guided PCI was evaluated on Major adverse cardiac events (MACE) at 1 year (OR 0.78, 95% CI 0.59-1.04, p=0.09). Fractional flow reserve (FFR) guided percutaneous coronary intervention resulted in no significant difference in major adverse cardiac events at 1 year compared to angiography guided PCI (OR 0.78, p=0.09).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: